Every January, supplement brands guess where demand will go. We do it differently: our 18 wellness tracks each carry a live demand signal from our market monitoring, and once a year we rank them all in one place. Here is the 2026 board — use it to decide where your next SKU lives.
The full board, ranked
| Track | 2026 signal |
|---|---|
| Base Nutrition (VMS) | ↗ +10.6% · steady core demand |
| Immune Health | ↗ #1 application category worldwide |
| Sleep & Mood | ↗↗ +26.6% · strongest repeat purchase |
| Focus & Cognition | ↗↗ ~+92.9% · nootropics boom |
| Longevity & Healthspan | ↗↗ ~+103.9% · highest baskets, strictest rules |
| Sports Nutrition | ↗ +16.3% · going mainstream |
| Hydration & Electrolytes | ↗↗ 2026's key growth driver |
| Gut Health | ↗↗ ~+37.9% · microbiome wave |
| Beauty From Within | ↗↗ ingestible beauty breakout |
| Herbal Wisdom & Adaptogens | ↗↗ ~+31.5% · our unreplicable home turf |
| Weight Management | → GLP-1 era: repositioned, not retired |
| Women's Health | ↗ menopause · UTI · fertility, three engines |
| Men's Health | ↗ underserved · lower competition |
| Cardiovascular | → large but maturing (+4.1%) |
| Bone & Joint | ↗ fastest-growing senior segment |
| Eye Health | ↗ screen-era daily essential |
| Kids Nutrition | ↗ strongest parental spend |
| Pet Supplements | ↗ humanization premium, low rivalry |
Sources: figures are directional estimates compiled from aggregated public market research (2024–2026), for planning purposes. Verify against current category reports before investment decisions.
How to read it
Sleep & Mood keeps the crown. Melatonin gummies remain the single strongest repeat-purchase line in our portfolio, and low-dose formats (1–5 mg) keep opening new demographics — daytime calm, travel, "wind-down without the hangover." If you need one hero SKU, this is still the highest-probability bet.
Hydration is the volume story. Electrolyte stick packs carry the lowest trial MOQ in our portfolio (from 10,000 sticks) precisely because first-time brands keep choosing them: light to ship, cheap to trial, and the sugar-free/keto variants let one line serve three diets.
Weight management didn't die with the laxative era — it got repositioned. The GLP-1 wave turned "weight loss" into "nutritional support": fiber satiety, micronutrient top-ups while on GLP-1s, blood-sugar-friendly teas. The brands that win here are the ones that refuse stimulant-laxative claims — which is exactly how we screen the track.
Longevity is the margin story. Ubiquinol, urolithin A and creatine command premium price points, but every formula routes through compliance review first — longevity claims are where regulators look hardest.
What we'd do with this
Pick one high-growth track for your hero product, one stable track for cash flow, and one emerging track where you can be early. Three SKUs, one manufacturer, one compliance framework — that's how our fastest-growing partners started.
Get a line-item quote — formula, dosage form, packaging, MOQ — within one business day.
Get a Quote →